MedKoo Cat#: 462447 | Name: Teijin Compound 1 HCl
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Teijin compound 1 is an antagonist of chemokine (C-C motif) receptor 2b (CCR2b).

Chemical Structure

Teijin Compound 1 HCl
Teijin Compound 1 HCl
CAS#1313730-14-1

Theoretical Analysis

MedKoo Cat#: 462447

Name: Teijin Compound 1 HCl

CAS#: 1313730-14-1

Chemical Formula: C21H22Cl2F3N3O2

Exact Mass: 475.1041

Molecular Weight: 476.32

Elemental Analysis: C, 52.95; H, 4.66; Cl, 14.88; F, 11.97; N, 8.82; O, 6.72

Price and Availability

Size Price Availability Quantity
100mg USD 1,250.00 2 Weeks
200mg USD 1,950.00 2 Weeks
500mg USD 2,950.00 2 Weeks
1g USD 4,250.00 2 Weeks
2g USD 6,350.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
Synonym
Teijin Compound 1 HCl
IUPAC/Chemical Name
(R)-N-(2-((1-(4-chlorobenzyl)pyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide hydrochloride
InChi Key
PGUQBBISBKGQDC-GMUIIQOCSA-N
InChi Code
InChI=1S/C21H21ClF3N3O2.ClH/c22-17-6-4-14(5-7-17)12-28-9-8-18(13-28)27-19(29)11-26-20(30)15-2-1-3-16(10-15)21(23,24)25;/h1-7,10,18H,8-9,11-13H2,(H,26,30)(H,27,29);1H/t18-;/m1./s1
SMILES Code
O=C(CNC(C1=CC(C(F)(F)F)=CC=C1)=O)N[C@@H]2CCN(CC3=CC=C(Cl)C=C3)C2.Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 476.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Moree, W.J., Kataoka, K.-i., Ramirez-Weinhouse, M.M., et al. Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure-activity relationships of diamine derivatives. Bioorg. Med. Chem. Lett. 14(21), 5413-5416 (2004). 2: Hall, S.E., Mao, A., Nicolaidou, V., et al. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5. Mol. Pharmacol. 75(6), 1325-1336 (2009). 3: Calin M, Stan D, Schlesinger M, Simion V, Deleanu M, Constantinescu CA, Gan AM, Pirvulescu MM, Butoi E, Manduteanu I, Bota M, Enachescu M, Borsig L, Bendas G, Simionescu M. VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes. Eur J Pharm Biopharm. 2015 Jan;89:18-29. doi: 10.1016/j.ejpb.2014.11.016. Epub 2014 Nov 28. PMID: 25438248. 4: Roblek M, Calin M, Schlesinger M, Stan D, Zeisig R, Simionescu M, Bendas G, Borsig L. Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis. J Control Release. 2015 Dec 28;220(Pt A):341-347. doi: 10.1016/j.jconrel.2015.10.055. Epub 2015 Oct 30. PMID: 26522070; PMCID: PMC6322646.